Merck Serono Submits Application For Extension Of Indication For Rebif(R) In Europe

Links shared publicly online about this topic.

  • 184
    total visits

Merck Serono Submits Application For Extension Of Indication For Rebif(R) In Europe

medicalnewstoday.com —

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has submitted an application to the European Medicines Agency (EMA) to extend the indication of Rebif®, its

View full resource at medicalnewstoday.com

Tags: Merck & Co., Merck KGaA, Medical

  • Share

Most Recently Shared on June 29, 2011 at 11:06 am By:

mnt_drugapprov MNT Drug Approvals

Merck Serono Submits Application For Extension Of Indication For Rebif(R) In Europe http://mnt.to/3XMv #regulatory

11 months ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Multiple Scl MNT Multiple Scl

Advertisement